Aadi Bioscience, Inc. — Form D

Aadi Bioscience, Inc. of MORRISTOWN, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2025-03-18. The offering totals $100.0M, of which $100.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (31)

Showing 25 of 31 people.

NameRoleLocation
Behzad AghazadehDirectorNew York, NY
Caley CasteleinDirectorSan Francisco, CA
Anupam DalalDirectorMORRISTOWN, NJ
Neil DesaiDirectorRye, NY
Karin HehenbergerDirectorMORRISTOWN, NJ
Mohammad HirmandDirectorSan Diego, CA
Dave LennonDirectorMORRISTOWN, NJ
Richard MarounDirectorMORRISTOWN, NJ
Emma ReeveDirectorNorfolk, VA
Baiteng ZhaoDirectorMORRISTOWN, NJ
Bryan BallExecutive OfficerMORRISTOWN, NJ
David DornanExecutive OfficerMORRISTOWN, NJ
Scott GiacobelloExecutive OfficerMORRISTOWN, NJ
Dave LennonExecutive OfficerMORRISTOWN, NJ
Neil DesaiExecutive OfficerRye, NY
Brendan DelaneyExecutive OfficerPacific Palisades, CA
Loretta ItriExecutive OfficerPacific Palisades, CA
Lance ThibaultExecutive OfficerGaithersburg, MD
Karin HenebergerDirectorPacific Palisades, CA
Paul M WeissDirectorMadison, WI
Muneer SatterDirectorCincinnati, OH
Steven M PrelackDirectorCincinnati, OH
Anupam M DalalDirectorCincinnati, OH
Joseph GardnerDirectorCincinnati, OH
Joseph GardnerExecutive OfficerCincinnati, OH

Other filings by this issuer (4)

FiledFormOfferingSold
2022-10-11D$72.5M$72.5M
2021-09-10D$82.5M$82.5M
2021-09-10D$155.0M$155.0M
2017-03-30D$41.8M$41.8M

More